BRIEF-Vascepa Showed Fall In Atherogenic Lipid, Inflammatory Markers In Statin Treated Patients With Reduced Kidney Function

1 分钟阅读

April 12 (Reuters) - Amarin Corporation PLC:

* VASCEPA SHOWED FALL IN ATHEROGENIC LIPID, INFLAMMATORY MARKERS IN STATIN-TREATED PATIENTS WITH REDUCED KIDNEY FUNCTION, PERSISTENT HIGH TRIGLYCERIDES Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below